Sumitomo Chemical unit Sumitomo Pharma rejects Gotham City Research report, sees no need to restate financials

• Sumitomo Pharma, a Sumitomo Chemical subsidiary, acknowledged a Gotham City Research report published Aug. 3, 2026.
• Sumitomo Pharma said it has not confirmed allegations of financial misstatements or inappropriate accounting.
• Sumitomo Pharma said it has no plans to revise previously disclosed financial statements.
• Financial statements received an unqualified audit opinion, according to the company.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sumitomo Chemical Co. Ltd. published the original content used to generate this news brief on August 04, 2026, and is solely responsible for the information contained therein.